OBJECTIVE: There is a scarcity of data on ambulatory blood pressure (ABP) in HIV-infected individuals. The aim of the study was to identify possible predictors of ABP in HIV-infected individuals. METHODS: From a cohort of 542 HIV-infected patients, ABP monitoring was undertaken in 77 patients with high office blood pressure (BP) readings and without antihypertensive treatment. RESULTS: 24-h and daytime ABPs were associated with HIV duration (r=0.24-0.33, p=0.004-0.033), but not with duration of combined antiretroviral therapy. In multivariate linear regression analyses with the different ABPs as dependent variables, HIV duration (unstandardized beta=0.41-0.89, p=0.008-0.045) and log-transformed urinary albumin excretion (p=0.003-0.043) were predictors of all 24-h and daytime ABPs. Multiple logistic regression analysis revealed HIV duration (OR=1.14/year (95% CI 1.03-1.26)) as predictor of hypertension defined according to daytime ABP. Nocturnal hypertension was observed in 81%, white coat hypertension was present in 26%. CONCLUSIONS: HIV duration was an independent predictor of ABP and hypertension in a selected group of HIV-infected individuals. Nocturnal hypertension was prevalent, and white coat hypertension was present in one fourth of the patients.
OBJECTIVE: There is a scarcity of data on ambulatory blood pressure (ABP) in HIV-infected individuals. The aim of the study was to identify possible predictors of ABP in HIV-infected individuals. METHODS: From a cohort of 542 HIV-infectedpatients, ABP monitoring was undertaken in 77 patients with high office blood pressure (BP) readings and without antihypertensive treatment. RESULTS: 24-h and daytime ABPs were associated with HIV duration (r=0.24-0.33, p=0.004-0.033), but not with duration of combined antiretroviral therapy. In multivariate linear regression analyses with the different ABPs as dependent variables, HIV duration (unstandardized beta=0.41-0.89, p=0.008-0.045) and log-transformed urinary albumin excretion (p=0.003-0.043) were predictors of all 24-h and daytime ABPs. Multiple logistic regression analysis revealed HIV duration (OR=1.14/year (95% CI 1.03-1.26)) as predictor of hypertension defined according to daytime ABP. Nocturnal hypertension was observed in 81%, white coat hypertension was present in 26%. CONCLUSIONS: HIV duration was an independent predictor of ABP and hypertension in a selected group of HIV-infected individuals. Nocturnal hypertension was prevalent, and white coat hypertension was present in one fourth of the patients.
Authors: Ingjerd W Manner; Marius Trøseid; Olav Oektedalen; Morten Baekken; Ingrid Os Journal: J Clin Hypertens (Greenwich) Date: 2012-10-26 Impact factor: 3.738
Authors: Maria Leticia R Ikeda; Nêmora T Barcellos; Paulo R Alencastro; Fernando H Wolff; Ajácio B M Brandão; Flávio D Fuchs; Sandra C Fuchs Journal: ScientificWorldJournal Date: 2013-10-21
Authors: Shia T Kent; Samantha G Bromfield; Greer A Burkholder; Louise Falzon; Suzanne Oparil; Edgar T Overton; Michael J Mugavero; Joseph E Schwartz; Daichi Shimbo; Paul Muntner Journal: PLoS One Date: 2016-02-16 Impact factor: 3.240
Authors: Ana Gómez-Berrocal; Ignacio De Los Santos-Gil; Daniel Abad-Pérez; Ángela Gutiérrez-Liarte; Patricia Ibáñez-Sanz; Jesús Sanz-Sanz; Carmen Suárez Journal: J Int Assoc Provid AIDS Care Date: 2020 Jan-Dec